Please login to the form below

Not currently logged in
Email:
Password:

atrial fibrillation

This page shows the latest atrial fibrillation news and features for those working in and with pharma, biotech and healthcare.

BMS builds case for cardiovascular drug mavacamten with new analysis

BMS builds case for cardiovascular drug mavacamten with new analysis

In both obstructive or non-obstructive HCM patients, physical exertion can cause fatigue or shortness of breath, and has also been associated with increased risks of atrial fibrillation, stroke, heart failure

Latest news

More from news
Approximately 10 fully matching, plus 118 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

    Technology is another important enabler - as seen along the North West coast, where they are using portable ECG technology to screen for atrial fibrillation (AF) in an attempt to bring down

  • Cardiovascular disease: The scale of the challenge Cardiovascular disease: The scale of the challenge

    As the audit reveals, too many people with high risk conditions such as atrial fibrillation – a type of irregular heartbeat associated with the most serious strokes and heart attacks – are either

  • The Week After

    The Week After looks at the risks associated with atrial fibrillation - the teaser looks to capture the attention of cardiology to step in and act.

  • What is changing in cardiovascular disease care?

    Improving the detection and management of high-risk conditions, such as high blood pressure, high cholesterol and Atrial Fibrillation (AF) that can cause CVD, as well as many cases of dementia,

  • Artificial Intelligence in healthcare

    enough for you, the National Institute for Health and Care Excellence (NICE) has approved the use of ‘AliveCor’, which is a mobile heart monitor that can detect, monitor, and manage atrial ... fibrillation – a potentially fatal irregular heart

More from PMHub
Approximately 1 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...